Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33 Clinical Trial Not Allowed)

Funding Opportunity RFA-AI-21-007 from the NIH Guide for Grants and Contracts. To support the design of novel tuberculosis (TB) vaccine candidates that exploit innovative approaches and their advancement into preclinical animal model testing. This funding opportunity will use a milestone driven, biphasic award mechanism to fund high risk/exploratory research. Transition to the second phase depends on the successful completion of milestones.
Source: NIH Funding Opportunities (Notices, PA, RFA) - Category: Research Source Type: funding